FUROSEMIDE TABLETS,

The Defense Logistics Agency awarded Cardinal Health, Inc. (CAGE 00E55) a delivery order under the IDIQ contract SPE2DX-25-D-8022 for the supply of Furosemide tablets, with a total value of $5.33 and an award date of August 1, 2026. The item, identified by NSN 6505000623336 and NDC 00409-1271-01/21, is delivered in a single shipment of one bottle to USNS ABLE T-AGOS 20 at FPO AP 96660 under FOB Destination terms, meaning the contractor bears all transportation costs and risks until delivery. The contract falls under NAICS code 424210 and is designated as a small business set-aside with the awardee certified as a Small Disadvantaged Women-Owned Business. Delivery is due by August 3, 2026, and acceptance occurs at the destination upon government inspection, with payment processed via Fast Pay Net 15 to the remittance address in Columbus, Ohio. Invoicing must comply with DFARS 252.232-7003, typically requiring electronic submission through WAWF. The contract incorporates FAR clauses 52.212-1, 52.212-3, and 52.212-4 by reference, with delivery terms indicated as “SEE SCHEDULE.” Packaging, marking, and labeling follow MILSTRIP procedures and likely align with MIL-STD-129 and MIL-STD-130, though specific details are deferred to attached base contract documents, including PPVG GEN V SPE2DX-25-D-8022 FLEET MILSTRIP BASE ADMIN.pdf. Financial identifiers include BX 97X4930, SCBX 0012620, and S33189, with the base contract’s ceiling at $20 million but only a single CLIN currently active. The contract administration is managed by DLA Troop Support Med Support Chain FSB in Philadelphia, with Contracting Officer Lisa Quinn and local administrators Michelle Pampel and Catherine Gilbert as key contacts. No option periods, special requirements, or evaluation factors are detailed beyond the award notice, and while the DPAS clause